Asociația Română de Cercetare Oncologică pentru Femei

Website

Asociația Română de Cercetare Oncologică pentru Femei Asociația Română de Cercetare Oncologică pentru Femei (A.R.C.O.F.)

a fost fondată de un grup de medici oncologi dedicați promovării cercetării translaționale, a inovației și a medicinei personalizate în oncologia feminină.

🌿 Există momente în care cuvintele nu ajung. Când oboseala nu e doar fizică. Când zâmbești pentru ceilalți, dar în inter...
03/05/2026

🌿 Există momente în care cuvintele nu ajung. Când oboseala nu e doar fizică. Când zâmbești pentru ceilalți, dar în interior duci singură o povară uriașă.
Dacă trăiești cu un diagnostic de cancer de sân , știi exact despre ce vorbim.
Și tocmai de aceea există ONKOGAID RETREAT.
Nu este un eveniment medical. Nu este o conferință. Este un spațiu creat special pentru tine - un loc în care nu trebuie să fii puternică, în care nu trebuie să explici nimic și în care nu ești singură.
Timp de 4 zile la Bran, vei fi înconjurată de femei care înțeleg. Femei care au trecut sau trec prin același drum. Femei cu care poți să taci, să plângi, să râzi și să respiri, fără să te simți o povară pentru nimeni.
💚 Pentru că una dintre cele mai vindecătoare lucruri nu este un tratament sau un protocol - ci să știi că nu ești singură.

Ce vei găsi acolo:
Nu doar activități frumoase, ci instrumente reale pentru a te reconecta cu tine.
🧘 Yoga & TRE - pentru un corp care a dus atât de mult
📓 Journaling ghidat - pentru emoțiile care nu și-au găsit încă cuvintele
🌿 Plimbări mindful în natură - pentru momentele în care capul are nevoie de liniște
🍽️ Workshop nutriție - pentru că îngrijirea de sine începe cu ce pui pe masă
🔥 Foc de tabără - pentru povești spuse sincer, fără filtre
🌙 Mindfulness de seară - pentru nopțile care uneori par prea lungi

Cum a fost posibil acest retreat?
ARCOF a câștigat o bursă din partea Gilead Sciences Romania Fellowship 2025 - o recunoaștere a muncii noastre de ani de zile alături de pacientele cu cancer de sân. Cu ajutorul acestei finanțări, am reușit să facem retreatul accesibil: contribuția participantelor este de doar 500 lei, care acoperă 3 nopți de cazare, toate mesele și toate activitățile.
Pentru că fiecare femeie merită această pauză.

Alături de tine vor fi:
👩‍⚕️ Din partea ARCOF: Dr. Adelina Gheorghe, Dr. Elena Iovănescu, Dr. Dana Stănculeanu, Dr. Lidia Kajanto, Dr. Bogdan Georgescu, Dr. Isabela Komporaly, alături de Psih. Petronela Rotar
Medici și specialiști care nu vin doar cu expertiză, ci cu empatie, cu prezență și cu dorința sinceră de a fi acolo pentru tine.

📍 Transylvanian Inn, Bran
📅 10-13 Mai 2026
💰 500 lei/persoană: cazare 3 nopți + mese + toate activitățile
Locuri limitate.
📲 Înscrie-te pe WhatsApp: +40770785524 (Dr. Adelina Gheorghe), +40748309619 (Dr. Elena Iovănescu)
📩 sau la: [email protected]
Vino. Meriti acest timp pentru tine.
💚

🌍✨ Save the Date!We are proud to announce the Second Edition of the Global Gynecologic Oncology Hub.📍 Bucharest, Romania...
27/04/2026

🌍✨ Save the Date!

We are proud to announce the Second Edition of the Global Gynecologic Oncology Hub.

📍 Bucharest, Romania
📅 6–8 May 2027

Join leading experts, researchers, and clinicians for three days dedicated to innovation, translational research, early discovery, and shaping the future of gynecologic oncology.

More details coming soon.

Last weekend, ARCOF hosted the first edition of the Global Gynecologic Oncology Hub and we are overwhelmed with gratitud...
30/03/2026

Last weekend, ARCOF hosted the first edition of the Global Gynecologic Oncology Hub and we are overwhelmed with gratitude.
Thank you to the 300+ attendees who chose to be present, to listen, to ask the hard questions, and to build together the future of gynecologic oncology in Romania and beyond.
Thank you to our sponsors and our strategic partners NOGGO and ENGOT, without their unwavering support, none of this would have been possible.
Thank you to our sponsors - your commitment made this conference possible.
A heartfelt thank you to our strategic partners NOGGO and ENGOT - collaboration and trust are the foundation of everything we are building together. Without their unwavering support, none of this would have been possible.
A special thank you to UMF “Carol Davila” for their wonderful support of this conference.
Thank you to our international and Romanian speakers who took the stage and brought with them years of research, compassion, and clinical excellence.
✨ We are not done talking about what happened in that room. In the coming days, we will be sharing a deep dive into each of the moments that made this conference extraordinary because every single one of them deserves its own story.
But here is a first glimpse:
🔬 Presentations and discussions at the highest level — cutting-edge science on gynecologic cancers, in service of patients.
🤝 ARCOF–NOGGO–ENGOT Innovation Hub & Clinical Trials Partnership — Romania on the map of European clinical research. (Full story coming soon.)
🏅 Honoris Causa Award presented to Prof. Dennis Slamon — a historic moment we cannot wait to share with you in full. (Coming soon.)
🩺 Roundtable: "Advancing Prevention and Awareness in Women's Cancer in Romania" — with the Minister of Health, international advisors, ARCOF, sponsors, and FAQ Health. An honest conversation that needs to be heard. (Full post coming soon.)
🎓 Launch of the ARCOF Oncology Circle for Students — the next generation steps in. (Coming soon.)
Stay with us. The best stories are just getting started.

📢 Global Gynecologic Oncology Hub 2026We are pleased to announce that the Global Gynecologic Oncology Hub 2026 is accred...
23/03/2026

📢 Global Gynecologic Oncology Hub 2026

We are pleased to announce that the Global Gynecologic Oncology Hub 2026 is accredited with 18 CME credits for the main program — with additional credits available from dedicated courses, leading to an even higher total CME opportunity.

👉 Participants will benefit from a comprehensive scientific program combining plenary sessions with hands-on courses designed to support continuous professional development.

🔬 Workshops and courses are currently undergoing separate accreditation.

📍 Bucharest, Romania
📅 March 26–28, 2026

✨ An event designed to integrate translational science, clinical practice, and medical education.

\\\\

Suntem încântați să anunțăm că Global Gynecologic Oncology Hub 2026 este acreditat cu 18 puncte CME pentru programul principal — iar cursurile dedicate vor aduce puncte suplimentare, rezultând un total și mai mare de credite educaționale.

👉 Participanții vor avea oportunitatea de a acumula credite de Educație Medicală Continuă într-un program științific complex, care acoperă atât sesiuni plenare, cât și cursuri aplicate pentru dezvoltare profesională.

🔬 Workshop-urile și cursurile sunt în curs de acreditare separată.

📍 București, România
📅 26–28 martie 2026

✨ Un eveniment construit pentru a conecta cercetarea translațională, practica clinică și educația medicală continuă.



📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026We are pleased to welcome *Prof. Dr. James Brenton* as a featu...
19/03/2026

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026

We are pleased to welcome *Prof. Dr. James Brenton* as a featured speaker at the *Global Gynecologic Oncology Hub 2026* in Bucharest.

Prof. Brenton is a globally recognized leader in *ovarian cancer research*, known for his work on tumor evolution, genomic instability, and mechanisms of treatment resistance. As a senior investigator at the *Cancer Research UK Cambridge Institute*, his research has significantly advanced our understanding of how ovarian cancers develop resistance to therapy and how this can be overcome.

At *GGOH 2026*, he will present:
🎤 *25 Years of Insights into Platinum-Based Resistance: From Discovery to Clinical Management*

Platinum resistance remains one of the central challenges in ovarian cancer treatment. Prof. Brenton will provide a comprehensive perspective, from early biological discoveries to current clinical strategies, highlighting how decades of research are shaping more effective, personalized approaches to overcome resistance.

📍 Bucharest, Romania
📅 March 26–28, 2026
🎓 Global Gynecologic Oncology Hub 2026
Theme: *Translational Research, Early Discovery, and the Shaping of Future Policy*

✨ Join us for a deep dive into one of the most critical challenges in ovarian cancer care.

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026We are pleased to welcome Prof. Dr. Philipp Harter as a featur...
16/03/2026

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026

We are pleased to welcome Prof. Dr. Philipp Harter as a featured speaker at the Global Gynecologic Oncology Hub 2026 in Bucharest.

Prof. Harter is a leading expert in gynecologic oncology and clinical trial research, widely recognized for his contributions to advancing treatment strategies in ovarian cancer. His work at Charité - Universitätsmedizin Berlin and within international cooperative groups has played a significant role in shaping modern therapeutic standards and evidence-based care in gynecologic malignancies.

At GGOH 2026, he will present:
🎤 Checkpoint Inhibitors: Phase I Discoveries to Gynecologic Oncology Approvals

Immunotherapy has transformed the oncology landscape, yet its integration into gynecologic cancer care has required careful clinical development and robust trial evidence. Prof. Harter will explore the journey of checkpoint inhibitors - from early-phase discoveries to clinical approvals, highlighting the key trials and translational insights that are redefining treatment options in gynecologic oncology.

📍 Bucharest, Romania
📅 March 26–28, 2026
🎓 Global Gynecologic Oncology Hub 2026
Theme: Translational Research, Early Discovery, and the Shaping of Future Policy

✨ Join us for insights into how immunotherapy is reshaping the future of gynecologic cancer treatment.

We are proud to announce that the Global Gynecologic Oncology Hub is officially endorsed by ENGOT – the European Network...
15/03/2026

We are proud to announce that the Global Gynecologic Oncology Hub is officially endorsed by ENGOT – the European Network of Gynaecological Oncological Trial Groups.

Together with leading experts, we advance research, innovation, and collaboration in gynecologic oncology.
Standing together for women’s health.

📍 Palace of Parliament, Bucharest
📅 March 26–28, 2026

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026We are honored to welcome *Prof. Dr. Victor Velculescu* as a f...
13/03/2026

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026

We are honored to welcome *Prof. Dr. Victor Velculescu* as a featured speaker at the *Global Gynecologic Oncology Hub 2026* in Bucharest.

Prof. Velculescu is a globally recognized pioneer in *cancer genomics and liquid biopsy technologies*, and Professor of Oncology at *Johns Hopkins University*. His work has helped define the genomic landscape of multiple cancers and has been instrumental in developing methods to detect tumor-derived DNA in the bloodstream.

At *GGOH 2026*, he will present:
🎤 *Circulating Tumor DNA: Clinical Validation and Implementation*

Liquid biopsy is rapidly transforming oncology, enabling non-invasive cancer detection, monitoring of treatment response, and early identification of relapse through tumor DNA circulating in blood. Prof. Velculescu will share insights on how *ctDNA technologies are moving from research to real-world clinical practice*, and what this means for the future of precision oncology.

📍 Bucharest, Romania
📅 March 26–28, 2026
🎓 Global Gynecologic Oncology Hub 2026
Theme: *Translational Research, Early Discovery, and the Shaping of Future Policy*

✨ Join us to hear from one of the scientists who helped make *liquid biopsy a reality in cancer medicine*.

👉 Save the date and stay tuned for more speaker highlights.

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026We are pleased to welcome Dr. Delia Mezzanzanica as a featured...
12/03/2026

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026

We are pleased to welcome Dr. Delia Mezzanzanica as a featured speaker at the Global Gynecologic Oncology Hub 2026 in Bucharest.

Dr. Mezzanzanica is a leading translational cancer researcher with extensive experience in tumor biology, immunology, and biomarker discovery in gynecologic malignancies. Her work has focused particularly on ovarian cancer, exploring the molecular mechanisms underlying tumor progression, therapeutic resistance, and the development of predictive biomarkers for treatment response.

At GGOH 2026, she will present:
🎤 Are Biomarkers Valid or Is Our Approach Incorrect? The HER2 vs. FRA Story

As precision oncology continues to reshape clinical practice, biomarker validation remains one of the key challenges in translating molecular discoveries into effective therapeutic strategies. Dr. Mezzanzanica will examine how biomarker interpretation can influence treatment decisions, using HER2 and folate receptor alpha (FRA) as illustrative examples.

Her talk will provide valuable insights into the complexities of biomarker-driven oncology and how translational research can refine patient selection for targeted therapies.

📍 Bucharest, Romania
📅 March 26–28, 2026
🎓 Global Gynecologic Oncology Hub 2026
Theme: Translational Research, Early Discovery, and the Shaping of Future Policy

✨ Join us for an insightful discussion on the future of biomarker-guided therapy in gynecologic oncology.

👉 Save the date and stay tuned for more updates.

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026We are pleased to welcome Prof. Dr. Oliver Dorigo as a feature...
12/03/2026

📢 Speaker Spotlight | Global Gynecologic Oncology Hub 2026

We are pleased to welcome Prof. Dr. Oliver Dorigo as a featured speaker at the Global Gynecologic Oncology Hub 2026, taking place in Bucharest.

Prof. Dorigo is a distinguished expert in gynecologic oncology and translational cancer research, with a strong focus on innovative therapeutic strategies and early-phase clinical development. His work bridges molecular biology, immunology, and clinical investigation, contributing to the development of novel treatment approaches for women with gynecologic cancers.

At GGOH 2026, he will present:
🎤 CAR-T Therapy for Solid Tumors: Early Phase Progress

Adoptive cellular therapies have revolutionized the treatment of hematologic malignancies, yet their application in solid tumors remains one of the most challenging frontiers in oncology. Prof. Dorigo will discuss the current progress of CAR-T therapies in solid tumors, highlighting emerging strategies designed to overcome tumor microenvironment barriers and improve therapeutic efficacy.

His talk will provide insights into how next-generation cellular therapies may reshape the future of treatment for gynecologic cancers and other solid tumors.

📍 Bucharest, Romania
📅 March 26–28, 2026
🎓 Global Gynecologic Oncology Hub 2026
Theme: Translational Research, Early Discovery, and the Shaping of Future Policy

✨ Join us for a forward-looking discussion on how cellular immunotherapy may expand the therapeutic landscape of solid tumors.

👉 Save the date and stay tuned for more speaker announcements.

Address

Șos. Pipera Nr. 48A, Bl. E, Ap. 610, Et. 6, Sector 2
București

Alerts

Be the first to know and let us send you an email when Asociația Română de Cercetare Oncologică pentru Femei posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share